ArticleFrontiers in neurology2025
The lactic dehydrogenase-to-albumin ratio predicts acute kidney injury in patients with intracerebral hemorrhage: a multicenter cohort study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Acute kidney injury incidence and mortality following spontaneous intracerebral hemorrhage: a systematic review and meta-analysis.Frontiers in medicine · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute kidney injury (AKI) is a common and serious complication in patients with intracerebral hemorrhage (ICH), contributing to poor clinical outcomes. The lactic dehydrogenase-to-albumin ratio (LAR) has emerged as a promising biomarker combining markers of cellular injury and systemic inflammation. However, its role in predicting AKI in ICH patients remains unexplored. Objective: This study aims to evaluate the predictive value of LAR for AKI in ICH patients and assess its potential to enhance predictive models for AKI risk. Methods: We conducted a retrospective, multicenter cohort study involving 6,465 patients with spontaneous ICH from three hospitals in China. LAR was calculated from routine laboratory values (lactic dehydrogenase and albumin), and its association with AKI was analyzed using logistic regression and receiver operating characteristic (ROC) curves. Subgroup analyses were performed to explore heterogeneity in the relationship between LAR and AKI. Results: Higher LAR values were significantly associated with increased risk of AKI. Patients with LAR >5.61 had a higher odds ratio (OR 2.51, 95% CI 2.13-2.96) for developing AKI compared to those with lower LAR. A dose-response relationship was observed, with progressively higher AKI risk across LAR quartiles. Incorporating LAR into existing predictive models improved the accuracy from 0.73 to 0.76 ( Conclusions: LAR is a reliable and cost-effective biomarker associated with AKI risk in ICH patients, with significant potential to enhance early detection and risk stratification; however, causality cannot be established due to the retrospective study design. Its incorporation into predictive models improves accuracy and provides a feasible tool for identifying high-risk patients. Further validation and long-term studies are needed to confirm its clinical utility across diverse populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.